+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cytomegalovirus Drug"

Cytomegalovirus Treatment Market by Diseases, Drug, Distribution Channel, Application - Global Forecast 2025-2030 - Product Thumbnail Image

Cytomegalovirus Treatment Market by Diseases, Drug, Distribution Channel, Application - Global Forecast 2025-2030

  • Report
  • October 2024
  • 181 Pages
  • Global
From
Cytomegalovirus (CMV) Treatment - Global Strategic Business Report - Product Thumbnail Image

Cytomegalovirus (CMV) Treatment - Global Strategic Business Report

  • Report
  • April 2025
  • 384 Pages
  • Global
From
Cytomegalovirus Infections Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Cytomegalovirus Infections Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 128 Pages
  • Global
From
Cytomegalovirus (CMV) Therapeutics Market 2024-2028 - Product Thumbnail Image

Cytomegalovirus (CMV) Therapeutics Market 2024-2028

  • Report
  • October 2024
  • 144 Pages
  • Global
From
Cytomegalovirus Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Cytomegalovirus Infection - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 80 Pages
  • Global
From
Antiviral Drugs Market by Mechanism of Action, Target Indication, Type of Drug Target, Type of Therapy and Key Geographies: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Antiviral Drugs Market by Mechanism of Action, Target Indication, Type of Drug Target, Type of Therapy and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • September 2022
  • 194 Pages
  • Global
From
Valganciclovir Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024-2032 - Product Thumbnail Image

Valganciclovir Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024-2032

  • Report
  • March 2024
  • 120 Pages
  • Global
From
West Nile - Pipeline Insight, 2024 - Product Thumbnail Image

West Nile - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Cytomegalovirus (CMV) Infection - Epidemiology Forecast to 2032 - Product Thumbnail Image

Cytomegalovirus (CMV) Infection - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Cytomegalovirus (CMV) Infection - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Cytomegalovirus (CMV) Infection - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Cytomegalovirus Treatment Market Analysis & Forecast to 2024-2034: Market By Drug Type; By Application; By Distribution Channel; and By Region - Product Thumbnail Image

Cytomegalovirus Treatment Market Analysis & Forecast to 2024-2034: Market By Drug Type; By Application; By Distribution Channel; and By Region

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Cytomegalovirus Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

Cytomegalovirus Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 111 Pages
  • Global
From
Global Cytomegalovirus Infections Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Cytomegalovirus Infections Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Cytomegalovirus Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology - Product Thumbnail Image

Cytomegalovirus Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology

  • Report
  • August 2024
  • 80 Pages
  • Global
From
Cytomegalovirus (HHV-5) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Cytomegalovirus (HHV-5) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 174 Pages
  • Global
From
Human cytomegalovirus 65 kDa Phosphoprotein (PP65 or 65 kDa Matrix Phosphoprotein or Tegument Protein UL83 or UL83) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Human cytomegalovirus 65 kDa Phosphoprotein (PP65 or 65 kDa Matrix Phosphoprotein or Tegument Protein UL83 or UL83) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 62 Pages
  • Global
From
  • 16 Results (Page 1 of 1)
Loading Indicator

The Cytomegalovirus Drug market is a subset of the Infectious Diseases Drugs market. It is composed of drugs used to treat cytomegalovirus (CMV) infections, a type of virus that can cause serious health problems in people with weakened immune systems. These drugs are used to reduce the severity of symptoms, prevent complications, and reduce the risk of transmission. Commonly used drugs include ganciclovir, valganciclovir, and foscarnet. The Cytomegalovirus Drug market is highly competitive, with many companies offering similar products. Some of the major players in the market include Gilead Sciences, Merck & Co., Pfizer, Novartis, and GlaxoSmithKline. Show Less Read more